Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin

By Wang Hongmin   Lim Precious J.   Vogel Bruce E.   Monteiro Mervyn J.  

Human Molecular Genetics, Vol. 15, Iss. 6, 2006-03 ,pp. : 1025-1041

Oxford University Press

Access to resources Recommend Favorite

Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models

By Tauffenberger Arnaud   Chitramuthu Babykumari P.   Bateman Andrew   Bennett Hugh PJ.   Parker J. Alex  

Human Molecular Genetics, Vol. 22, Iss. 4, 2013-02 ,pp. : 782-794

Oxford University Press

Access to resources Recommend Favorite

Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies

By Falzone Toms L.   Gunawardena Shermali   McCleary David   Reis Gerald F.   Goldstein Lawrence S.B.  

Human Molecular Genetics, Vol. 19, Iss. 22, 2010-11 ,pp. : 4399-4408

Oxford University Press

Access to resources Recommend Favorite

Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

By Chan Edmond Y.W.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1939-1951

Oxford University Press

Access to resources Recommend Favorite

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

By Borchelt D.R.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1927-1937

Oxford University Press

Access to resources Recommend Favorite